MPG.eBooks - Author Search Results

101

Intermittent pneumatic compression devices for the management of lymphedema : a review of clinical effectiveness and guidelines

by Tran, Khai, Argáez, Charlene
Published 2017

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

102

Silver diamine fluoride for the prevention and arresting of dental caries or hypersensitivity : a review of clinical effectiveness, cost-effectiveness and guidelines

by Yeung, Shirley S. T., Argáez, Charlene
Published 2017

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

103

Colistin for prophylactic use in non-cystic fibrosis bronchiectasis or COPD with exacerbations : a review of clinical and cost-effectiveness and guidelines

by Ho, Chuong, Severn, Melissa
Published 2017

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

104

Codeine for acute pain in patients undergoing orthopedic surgery : a review of clinical effectiveness

by Marchand, Dave K., McCormack, Suzanne
Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

105

Pharmacoeconomic review report: Risankizumab (Skyrizi) (AbbVie)

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

106

Pharmacoeconomic review report: Fluocinolone acetonide intravitreal implant (Iluvien) (Knight Therapeutics Inc.)

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

107

Pharmacoeconomic review report: Dolutegravir/Lamivudine (Dovato) (ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunodeficiency virus type1 (...

Published 2019

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

108

Clinical review report: Dolutegravir/Lamivudine (Dovato) : (ViiV Healthcare ULC)

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

109

Low carbohydrate diets for diabetes : a review of the clinical effectiveness and guidelines

by Chao, Yi-Sheng, Butcher, Robyn
Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

110

Acupuncture for chronic non-cancer pain : a review of clinical effectiveness, cost effectiveness, and guidelines

by Sutton, Desirée, McCormack, Suzanne
Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

111

Clinical review report: Fluocinolone acetonide intravitreal implant (Iluvien) (Knight therapeutics inc.)

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

112

Clinical review report: Safinamide (Onstryv) (Valeo Pharma Inc.) : indication: for add-on therapy to a regimen that includes levodopa for the treatment of the signs and symptoms of...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

113

Pharmacoeconomic review report: Teduglutide (Revestive) (Shire Pharmaceuticals Ireland Limited) : indication: treatment of adults and pediatric patients one year of age and above w...

Published 2020

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

114

Clinical review report: Certolizumab pegol (Cimzia) (UCB Canada Inc.) : indication: treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for syst...

Published 2020

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

115

Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication: for the treatment of adult patients with active ankylosing spondylitis who have responded i...

Published 2020

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

116

Pharmacoeconomic review report: Onabotulinumtoxin A (Botox) (Allergan inc.) : indication: for the prophylaxis of headaches in adults with chronic migraine (plus/minus 15 days per m...

Published 2019

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

117

Pharmacoeconomic review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication: indicated in addition to standard therapy for reducing disease activity in adult patients...

Published 2020

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

118

Experiences and perspectives on endoscopic ultrasound for the diagnosis and treatment of pancreatic diseases : a rapid qualitative review

by Smith, Andrea, MacDougall, Danielle
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

119

Capsaicin for acute or chronic non-cancer pain: a review of clinical effectiveness, safety, and cost-effectiveness

by Banerjee, Srabani, McCormack, Suzanne
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

120

Pharmacogenomic testing for medication selection : a rapid qualitative review

by Smith, Andrea, Loshak, Hannah
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”